Generic Oncology Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Generic Oncology Drugs Market to 2027 - Global Analysis and Forecasts by Molecular Type (Large Molecule, Small Molecule); Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Cervical Cancer, Others), and Geography

Request for Sample of this report

Buy now

Table of Content

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Generic Oncology Drugs Market – By Molecule Type
- 1.3.2 Global Generic Oncology Drugs Market – By Application
- 1.3.3 Global Generic Oncology Drugs Market – By Geography

2. Global Generic Oncology Drugs Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Generic Oncology Drugs– Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific – PEST Analysis
- 4.2.4 Middle East & Africa– PEST Analysis
- 4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinions

5. Global Generic Oncology Drugs Market – Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Growing Cancer Prevalence Across The Globe
- 5.1.2 New Drug Launches
- 5.1.3 Benefits Offered By Generic Drugs
5.2 Key Market Restraints
- 5.2.1 Pricing Pressure
5.3 Key Market Opportunities
- 5.3.1 Growing Pharmaceutical Industry in Emerging Economies
5.4 Future Trends
- 5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis

6. Generic Oncology Drugs Market – Global Analysis

6.1 Global Generic Oncology Drugs Market Revenue Forecasts And Analysis
6.2 Global Generic Oncology Drugs Market, By Geography - Forecasts And Analysis
6.3 Market Positioning of Key Players

7. Generic Oncology Drugs Market Analysis And Forecasts To 2027 – Molecule Type

7.1 Overview
7.2 Global Generic Oncology Drugs Market Share by Molecule Type 2018 & 2027 (%)
7.3 Large Molecules Market
- 7.3.1 Overview
- 7.3.2 Large Molecules Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Small Molecules Market
- 7.4.1 Overview
- 7.4.2 Small Molecules Market Revenue and Forecast to 2027 (US$ Mn)

8. Generic Oncology Drugs Market Analysis And Forecasts To 2027 – Indication

8.1 Overview
8.2 Global Generic Oncology Drugs Market Share by Indication 2018 & 2027 (%)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Stomach Cancer
- 8.4.1 Overview
- 8.4.2 Stomach Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Colorectal Cancer
- 8.5.1 Overview
- 8.5.2 Colorectal Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Breast Cancer
- 8.6.1 Overview
- 8.6.2 Breast Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Prostate Cancer
- 8.7.1 Overview
- 8.7.2 Prostate Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Liver Cancer
- 8.8.1 Overview
- 8.8.2 Liver Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Kidney Cancer
- 8.9.1 Overview
- 8.9.2 Kidney Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.10 Cervical Cancer
- 8.10.1 Overview
- 8.10.2 Cervical Cancer Market Revenue and Forecast to 2027 (US$ Mn)
8.11 Others
- 8.11.1 Overview
- 8.11.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

9. Generic Oncology Drugs Market Revenue and Forecasts to 2027 – Geographical Analysis

10. Asia Pacific Generic Oncology Drugs Market Revenue and Forecasts to 2027

11. Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027

11.1 Overview
11.2 Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3 Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)
11.4 Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)
11.5 Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)
11.6 South Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.6.1 South Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.6.2 South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)
- 11.6.3 South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)
11.7 Saudi Arabia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.7.1 Saudi Arabia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.7.2 Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)
- 11.7.3 Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)
11.8 UAE Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.8.1 UAE Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.8.2 UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)
- 11.8.3 UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

12. South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027

12.1 Overview
12.2 South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
12.3 South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)
12.4 South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)
12.5 South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)
12.6 Brazil Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
12.6.1.1 Brazil Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.2 Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

12.6.3 Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

12.6.4 Argentina Generic Oncology Drugs Market

12.6.4.1 Argentina Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.5 Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

12.6.6 Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

13. Generic Oncology Drugs Market – Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Generic Oncology Drugs Market, 2016-2019
13.3 Organic Growth Strategies
13.4 Inorganic Growth Strategies

14. Generic Oncology Drugs Market–Key Company Profiles

15. Appendix

15.1 About The Insight Partners
15.2 Glossary Of Terms

Description

The global generic oncology drugs market is expected to reach US$ 36,029.60 Mn in 2027 from US$ 21,200.00 in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.
Factors such as, growing cancer prevalence across the globe, new product launches and benefits offered by generic drugs are boosting the market over the years. In addition, the growing pharmaceutical industry in developing countries are likely to have a positive impact on the growth of the market in the coming years.
Generic drugs are copies of branded drugs. Their pharmacological effects are similar to the branded counterparts. Generic drugs are cost effective as the manufacturers have not invested in the development and marketing of the new drug. When a drug patent expires, other manufacturers apply for FDA approval in order to manufacture and sell the product. Hence generic drugs are cheaper than branded drugs. The generic drug have exactly the same effects, dosage, side effects, route of administration, safety, risks, and strength as the original branded drug. Generic drugs are important in oncology as some anticancer drugs are only offered as generics. In most of the cases like, children with acute lymphoblastic leukemia or women patients with early-stage breast cancer are treated with generics. Generic drugs are extensively used in supportive care. The most significant benefit of using generic drugs is the cost, which is up to 85% less than that of a branded drugs. Thus, these benefits offered by generic drugs is likely to enhance the market growth during the forecast period.
The global generic oncology drugs market, based on the indication was segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, kidney cancer, cervical cancer, others. In 2018, the lung cancer segment held the largest share of the market, by indication. The highest share of lung cancer segment attributes to the high prevalence of patients suffering with the lung cancer that can be treated with generic oncology drugs.
Some of the major primary and secondary sources included in the report for the Generic Oncology Drugs Market are the World Health Organization, British Generics Manufacturers Association, Centers for Disease Control and Prevention, Cancer Association of South Africa, Italian Association for Cancer Research, American Cancer Society, Indian Brand Equity Foundation, and others.